Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present
Authors
Keywords
-
Journal
Journal of Ovarian Research
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-03
DOI
10.1186/s13048-022-01004-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy
- (2022) Brigida Anna Maiorano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review
- (2021) Angeles Alvarez Secord et al. GYNECOLOGIC ONCOLOGY
- Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening
- (2021) Shengqing Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
- (2020) Won Suk Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
- (2018) Allen W. Zhang et al. CELL
- No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands
- (2018) M. Timmermans et al. EUROPEAN JOURNAL OF CANCER
- Who are the long-term survivors of high grade serous ovarian cancer?
- (2018) Claire Hoppenot et al. GYNECOLOGIC ONCOLOGY
- Angiogenesis Inhibitors for the Treatment of Ovarian Cancer
- (2018) Haihong Wang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
- (2018) Rebecca C. Arend et al. MOLECULAR CANCER RESEARCH
- Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer
- (2018) Jeremy Chien et al. Frontiers in Oncology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Application of Cell-free DNA Analysis to Cancer Treatment
- (2018) Ryan B. Corcoran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer
- (2016) Sandrina Lambrechts et al. EUROPEAN JOURNAL OF CANCER
- Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling
- (2016) Youn Jin Choi et al. JOURNAL OF PATHOLOGY
- Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer
- (2016) Andrew McPherson et al. NATURE GENETICS
- Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
- (2016) M. A. Eckert et al. Cancer Discovery
- Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer
- (2015) Alexandre A. B. A. da Costa et al. ANNALS OF SURGICAL ONCOLOGY
- Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression
- (2015) Alba Mota et al. BMC CANCER
- Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells
- (2015) Jennifer Munkley et al. BMC CANCER
- Computational systems biology approaches to anti-angiogenic cancer therapeutics
- (2015) Stacey D. Finley et al. DRUG DISCOVERY TODAY
- Why have ovarian cancer mortality rates declined? Part I. Incidence
- (2015) Victoria Sopik et al. GYNECOLOGIC ONCOLOGY
- BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk
- (2015) Fabrice Kwiatkowski et al. PLoS One
- Delineating cancer evolution with single-cell sequencing
- (2015) Nicholas E. Navin Science Translational Medicine
- Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
- (2015) Roland F. Schwarz et al. PLOS MEDICINE
- Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
- (2015) Alicia A Tone et al. BMC CANCER
- “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?
- (2014) Alison Davis et al. GYNECOLOGIC ONCOLOGY
- Cancer Evolution: Mathematical Models and Computational Inference
- (2014) Niko Beerenwinkel et al. SYSTEMATIC BIOLOGY
- Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial
- (2013) Hannah S. van Meurs et al. EUROPEAN JOURNAL OF CANCER
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- Cellular Heterogeneity and Molecular Evolution in Cancer
- (2012) Vanessa Almendro et al. Annual Review of Pathology-Mechanisms of Disease
- Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
- (2012) Hiroshi Haeno et al. CELL
- Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease
- (2012) Mauro Castellarin et al. JOURNAL OF PATHOLOGY
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer
- (2011) Charlotte KY Ng et al. JOURNAL OF PATHOLOGY
- Evolution of platinum resistance in high-grade serous ovarian cancer
- (2011) Susanna L Cooke et al. LANCET ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
- (2010) S L Cooke et al. ONCOGENE
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Tumor Spreading to the Contralateral Ovary in Bilateral Ovarian Carcinoma Is a Late Event in Clonal Evolution
- (2009) Francesca Micci et al. Journal of Oncology
- The clonal evolution of metastases from primary serous epithelial ovarian cancers
- (2008) Lalarukh Khalique et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now